Back to Search Start Over

Cofilin dysregulation alters actin turnover in frataxin-deficient neurons

Authors :
Francesc Palau
Belén Mollá
Federico V. Pallardo
Pilar Gonzalez-Cabo
Diana C. Muñoz-Lasso
Pablo Calap-Quintana
José Luis García-Giménez
Ministerio de Economía y Competitividad (España)
Instituto de Salud Carlos III
Fundación Ramón Areces
Generalitat Valenciana
Centro de Investigación Biomédica en Red Enfermedades Raras (España)
Source :
Scientific Reports, Vol 10, Iss 1, Pp 1-10 (2020), Scientific Reports, Digital.CSIC. Repositorio Institucional del CSIC, instname
Publication Year :
2020
Publisher :
Nature Portfolio, 2020.

Abstract

10 páginas, 3 figuras. Contiene material suplementario accesible en: https://doi.org/10.1038/s41598-020-62050-7<br />Abnormalities in actin cytoskeleton have been linked to Friedreich's ataxia (FRDA), an inherited peripheral neuropathy characterised by an early loss of neurons in dorsal root ganglia (DRG) among other clinical symptoms. Despite all efforts to date, we still do not fully understand the molecular events that contribute to the lack of sensory neurons in FRDA. We studied the adult neuronal growth cone (GC) at the cellular and molecular level to decipher the connection between frataxin and actin cytoskeleton in DRG neurons of the well-characterised YG8R Friedreich's ataxia mouse model. Immunofluorescence studies in primary cultures of DRG from YG8R mice showed neurons with fewer and smaller GCs than controls, associated with an inhibition of neurite growth. In frataxin-deficient neurons, we also observed an increase in the filamentous (F)-actin/monomeric (G)-actin ratio (F/G-actin ratio) in axons and GCs linked to dysregulation of two crucial modulators of filamentous actin turnover, cofilin-1 and the actin-related protein (ARP) 2/3 complex. We show how the activation of cofilin is due to the increase in chronophin (CIN), a cofilin-activating phosphatase. Thus cofilin emerges, for the first time, as a link between frataxin deficiency and actin cytoskeleton alterations.<br />Tis work was supported by grants from the Ministerio de Economía y Competitividad de España [Grant no. PI11/00678; SAF2015-66625-R] within the framework of the National R+ D+ I Plan and co-funded by the Instituto de Salud Carlos III (ISCIII)-Subdirección General de Evaluación y Fomento de la Investigación and FEDER funds; Fundación Ramón Areces (CIVP18A3899); the Generalitat Valenciana (ACOMP/2014/058; PROMETEO/2018/135). CIBERER is an initiative developed by the Instituto de Salud Carlos III in cooperative and translational research on rare diseases.

Details

Language :
English
ISSN :
20452322
Volume :
10
Issue :
1
Database :
OpenAIRE
Journal :
Scientific Reports
Accession number :
edsair.doi.dedup.....b0bf079744afed55d0942ff17d57f4b7